Incorporated in 2010, Nephrocare Health Services Ltd. operates a network of dialysis clinics offering services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness-focused support backed by an internal pharmacy model. The organisation has expanded its footprint across India and a few international locations through a clinic-based approach to dialysis care. As of 30 September 2025, the network included 519 clinics, with 51 facilities situated in the Philippines, Uzbekistan, and Nepal. In India, Nephrocare was present across 288 cities in 21 States and four Union Territories, with a majority of its centres located in tier II and tier III regions. During FY 2025, the company reported serving 29,281 patients and carrying out 2,885,450 dialysis sessions. It operated 5,562 dialysis machines as of the same date.
The company’s operational model includes in-clinic services, mobile dialysis formats, and care pathways that combine treatment and wellness programmes. It also collaborates with multiple hospitals to manage in-house dialysis units, which allows access to patients already receiving care within these facilities. Nephrocare’s service reach reflects a growing shift toward structured dialysis care in areas that have seen limited access historically. The organisation continues to expand its network based on demand for dialysis treatment linked to the rising detection of chronic kidney disease and end-stage renal conditions. As of 30 September 2025, Nephrocare reported having served 31,046 patients and conducted 1,591,377 treatments in India during the six-month period, according to the disclosed operational data.